PASITHEA THERAPEUTICS CORP. Number of Operating Segments
PASITHEA THERAPEUTICS CORP. (KTTA) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. number of operating segments for fiscal 2024 was 100.00%.
pure
| Period end | Number of Operating Segments 12 month |
|---|---|
| 2024-12-31 | 100.00% 10-K · filed 2025-03-24 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-30 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |